These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 14500173

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
    Roos JF, Lipman J, Kirkpatrick CMJ.
    Intensive Care Med; 2007 May; 33(5):781-788. PubMed ID: 17342515
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of cefepime in patients with the sepsis syndrome.
    Kieft H, Hoepelman AI, Knupp CA, van Dijk A, Branger JM, Struyvenberg A, Verhoef J.
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():117-22. PubMed ID: 8150754
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
    Barbhaiya RH, Knupp CA, Pfeffer M, Zaccardelli D, Dukes GM, Mattern W, Pittman KA, Hak LJ.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1387-91. PubMed ID: 1510432
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The pharmacokinetics of cefpirome--rationale for a twelve-hour dosing regimen.
    Craig WA.
    Scand J Infect Dis Suppl; 1993 Jul; 91():33-40. PubMed ID: 8290901
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of cefepime in cystic fibrosis patients.
    Huls CE, Prince RA, Seilheimer DK, Bosso JA.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1414-6. PubMed ID: 8363368
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The pharmacokinetics change of cefepime after Shuanghuanglian injection administration in subjects with the renal damage.
    Chen H, Min J, Li W, Zhao W, Mi S, Wang N, Zhu C.
    Drug Chem Toxicol; 2016 Jul; 39(2):129-36. PubMed ID: 26108148
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome.
    Jacolot A, Incagnoli P, Edouard AR, Tod M, Petitjean O, Samii K, Mimoz O.
    Intensive Care Med; 1999 May; 25(5):486-91. PubMed ID: 10401943
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cefepime dosing in the morbidly obese patient population.
    Rich BS, Keel R, Ho VP, Turbendian H, Afaneh CI, Dakin GF, Pomp A, Nicolau DP, Barie PS.
    Obes Surg; 2012 Mar; 22(3):465-71. PubMed ID: 22249886
    [Abstract] [Full Text] [Related]

  • 38. Disposition kinetics, bioavailability and renal clearance of cefepime in calves.
    Ismail MM.
    Vet Res Commun; 2005 Jan; 29(1):69-79. PubMed ID: 15727293
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
    Barbhaiya RH, Forgue ST, Gleason CR, Knupp CA, Pittman KA, Weidler DJ, Movahhed H, Tenney J, Martin RR.
    Antimicrob Agents Chemother; 1992 Mar; 36(3):552-7. PubMed ID: 1622165
    [Abstract] [Full Text] [Related]

  • 40. Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.
    Nicasio AM, Ariano RE, Zelenitsky SA, Kim A, Crandon JL, Kuti JL, Nicolau DP.
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1476-81. PubMed ID: 19188394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.